CollPlant Biotechnologies (CLGN) Earnings Analysis
CollPlant Biotechnologies (CLGN) next reports earnings on 2026-08-20, consensus EPS -0.2448 USD. Last quarter (2026-05-29) it beat with EPS -0.23 USD vs -0.2374 USD est (+3.1%). It has beaten estimates in 2/7 recent quarters (29%). Trailing P/E -0.31.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does CLGN next report earnings?
| Next earnings date | 2026-08-20 |
|---|---|
| Consensus EPS estimate | -0.2448 USD |
| Revenue estimate | 0.00B |
CLGN earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-29 | -0.23 USD | -0.2374 USD | +3.1% | Beat |
| 2026-03-26 | -0.67 USD | -0.2977 USD | -125.1% | Miss |
| 2025-11-26 | -0.27 USD | 0.38 USD | -171.1% | Miss |
| 2025-08-20 | -0.28 USD | -0.1 USD | -180% | Miss |
| 2025-05-28 | -0.13 USD | -0.37 USD | +64.9% | Beat |
| 2024-11-27 | -0.38 USD | -0.28 USD | -35.7% | Miss |
| 2024-08-20 | -0.37 USD | -0.35 USD | -5.7% | Miss |
Beat rate: 2/7 (29%) over reported quarters with consensus data.
CLGN valuation and analyst view
| Trailing P/E | -0.31 |
|---|---|
| Trailing EPS | -0.95539 USD |
| Price / book | 0.90 |
| Dividend yield | 0.00% |
| Market cap | 0.00B |
| Analyst consensus | Buy (4 buy / 1 hold / 0 sell) |
Related research pages
Frequently asked questions
When is CollPlant Biotechnologies (CLGN)'s next earnings date?
CollPlant Biotechnologies is next scheduled to report on 2026-08-20, with a consensus EPS estimate of -0.2448 USD and revenue estimate of 0.00B.
Did CLGN beat earnings last quarter?
In its 2026-05-29 report, CLGN posted EPS of -0.23 USD versus a -0.2374 USD estimate — a beat of 3.1%.
What is CLGN's earnings track record?
Over the last 7 reported quarters with consensus data, CLGN beat estimates 2 times (29%).
What is CLGN's current P/E ratio and EPS?
CLGN trades at a trailing P/E of -0.31 on trailing EPS of -0.9553942750831369 USD.
What do analysts rate CLGN?
Analyst consensus is "Buy" across 5 ratings (0 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell).